Navigation Links
Mesh Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Boston Scientific Transvaginal Mesh Litigation
Date:8/8/2013

New York, New York (PRWEB) August 08, 2013

Mesh lawsuits (http://www.mesh-lawyers.net/) involving product liability claims against Boston Scientific Corp. are moving forward in the multidistrict litigation underway in U.S. District Court, Southern District of West Virginia. According to a Pretrial Order dated August 7, 2013, Judge Joseph Goodwin has established parameters for the selection of cases for the litigation’s bellwether trials. The Order directs the parties to simultaneously submit amended bellwether selections by Monday, August 12, 2013, from which the Court will ultimately select five transvaginal mesh lawsuits for trial. According to the Order, the Court has scheduled three rounds of bellwether trials, with the first scheduled to begin on February 11, 2014. (In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation- MDL No. 2326)

“Our firm is pleased to see this litigation moving forward, as we continue to hear from women who suffered serious injuries, allegedly due to transvaginal mesh products marketed by Boston Scientific and other companies,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices, including hundreds of women in vaginal mesh lawsuits. Firm Partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee in the federal Boston Scientific transvaginal mesh litigation. Bernstein Liebhard LLP continues to evaluate mesh lawsuits on behalf of alleged victims of serious transvaginal mesh complications.

Transvaginal Mesh Lawsuits
Since 2008, transvaginal mesh products used to treat pelvic organ prolapse and stress urinary incontinence have been the subject of two U.S. Food & Drug Administration (FDA) safety alerts regarding the high rate of serious complications associated with such devices. Court documents indicate that more than 5,300 mesh lawsuits have been filed against Boston Scientific in the Southern District of West Virginia. Plaintiffs allege that various pelvic mesh products marketed by the company were defectively designed and manufactured. They further claim that Boston Scientific failed to provide adequate warnings to patients and doctors about their serious risks.

The Boston Scientific litigation is just one of several that have been established in the Southern District of West Virginia for vaginal mesh lawsuits. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs Steering Committees for: In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2327”);and In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”).

Mr. Grand is also serving as Co-Liaison Counsel in two multicounty litigations currently underway in New Jersey’s Atlantic County Superior Court for C.R. Bard and Ethicon vaginal mesh lawsuits. He was also a member of the trial team on the first Ethicon trial in that proceeding, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Women injured by vaginal mesh devices marketed by Boston Scientific and other companies may be eligible to file a mesh lawsuit seeking compensation for medical expenses, pain and suffering and other damages. Learn More about transvaginal mesh complications by visiting Bernstein Liebhard LLP’s website, or by contacting one of the Firm’s attorneys directly at 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(800) 511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (800) 511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.mesh-lawyers.net/

Read the full story at http://www.prweb.com/releases/mesh-lawsuit/transvaginal-mesh-lawsuit/prweb11010645.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
2. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
3. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
4. New Lawsuit Alleges Teen Molestation by Ex-Deputy
5. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
6. New Lawsuit on Propecia: Severe Adverse Events
7. New Lawsuit on Accutane Crohn’s Disease: Severe Adverse Events
8. New Lawsuit alleges Actos caused Bladder Cancer
9. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
10. Wright & Schulte File Skechers Lawsuit on Behalf of Ohio Woman Who Fell, Suffered Broken Wrist Allegedly Due to Use of Skechers Shape-Ups
11. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: